Category
Glp 1 Research
5 articles
GLP-1 Receptor Agonists: From Diabetes to Metabolic Care
Tracing GLP-1 receptor agonists' research history, from their origins in diabetes treatment to their expanding role in obesity and metabolic health management.
Triple Receptor Agonism: Retatrutide Research Explained
An in-depth look at retatrutide's GLP-1, GIP, and glucagon receptor co-agonism, the phase 2 trial data, and what triple activation means for metabolic science.
Visceral vs Subcutaneous Fat: Why Location Matters
Not all body fat behaves the same. The distinct metabolic activity of visceral and subcutaneous adipose tissue, and why fat distribution drives disease risk.
The Future of Weight Management: Beyond Lifestyle Advice
From lifestyle intervention through bariatric surgery to next-generation pharmacotherapy: an evidence-based look at how obesity treatment research is evolving.
Tirzepatide Research: The Dual GIP/GLP-1 Agonist Explained
A research-focused overview of tirzepatide's dual GIP and GLP-1 mechanism, the SURMOUNT trial data, and why dual agonism outperforms single-receptor therapies.